Region | Number of Phase I trials registered |
---|---|
Africa | 103 (0 registered between 1995/2000) |
Central America | 84 |
East Asia (including Japan) | 659 |
Middle East | 267 |
South America | 128 (0 registered between 1995/2000) |
South Asia | 94 (81 registered in India) |
South East Asia | 120 |